Related Experiment Video
Updated: Oct 12, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Mitochondrial Metabolism in Melanoma
Christina Huang1, Rakan H Radi1, Jack L Arbiser1,2,3
1Department of Dermatology, School of Medicine, Emory University, Atlanta, GA 30322, USA.
Abstract:
Melanoma and its associated alterations in cellular pathways have been growing areas of interest in research, especially as specific biological pathways are being elucidated. Some of these alterations include changes in the mitochondrial metabolism in melanoma. Many mitochondrial metabolic changes lead to differences in the survivability of cancer cells and confer resistance to targeted therapies. While extensive work has gone into characterizing mechanisms of resistance, the role of mitochondrial adaptation as a mode of resistance is not completely understood. In this review, we wish to explore mitochondrial metabolism in melanoma and how it impacts modes of resistance. There are several genes that play a major role in melanoma mitochondrial metabolism which require a full understanding to optimally target melanoma. These include BRAF, CRAF, SOX2, MCL1, TRAP1, RHOA, SRF, SIRT3, PTEN, and AKT1. We will be discussing the role of these genes in melanoma in greater detail. An enhanced understanding of mitochondrial metabolism and these modes of resistance may result in novel combinatorial and sequential therapies that may lead to greater therapeutic benefit.
Insights
Mitochondrial metabolism changes impact melanoma cell survival and therapy resistance. Understanding these changes and key genes can lead to new melanoma treatments.
Area of Science:
- Oncology
- Cell Biology
- Metabolic Research
Background:
- Melanoma research increasingly focuses on cellular pathway alterations.
- Mitochondrial metabolism changes are implicated in melanoma cell survival and drug resistance.
- The role of mitochondrial adaptation in melanoma resistance requires further elucidation.
Purpose of the Study:
- To explore mitochondrial metabolism in melanoma.
- To understand how mitochondrial metabolism impacts therapeutic resistance.
- To identify key genes involved in melanoma mitochondrial metabolism for targeted therapy.
Main Methods:
- Review of existing literature on melanoma and mitochondrial metabolism.
- Analysis of the roles of specific genes (BRAF, CRAF, SOX2, MCL1, TRAP1, RHOA, SRF, SIRT3, PTEN, AKT1) in melanoma.
- Discussion of mitochondrial adaptation as a resistance mechanism.
Main Results:
- Mitochondrial metabolic alterations significantly affect melanoma cell viability.
- Specific genes critically influence melanoma's mitochondrial metabolic landscape.
- Understanding these pathways is crucial for overcoming therapeutic resistance.
Conclusions:
- Mitochondrial metabolism is a key factor in melanoma progression and resistance.
- Targeting specific genes involved in mitochondrial metabolism offers therapeutic potential.
- Further research may yield novel combinatorial and sequential therapies for melanoma.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mitochondrial Membranes
Mitochondria
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...

